Pharmaceutically acceptable salt of N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperdine-1-carboxamide
PK140678AUndetermined Publication Date: 2010-04-21PFIZER PROD INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200901060
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-04-21
Abstract
The present invention relates to pharmaceutically acceptable salt of a compound of Formula (I) Composition containing the compound; and uses of the compound in treating diseases or conditions associated with fatty acid amide hydrolase (FAHH) activity.
Need to check novelty before this filing date? Find Prior Art